Compare VRUS to:
After Hours: 20.23 N/A (N/A) 1:06pm ET
| Last Trade: | 20.23 |
|---|---|
| Trade Time: | Dec 24 |
| Change: | |
| Prev Close: | 19.98 |
| Open: | 20.11 |
| Bid: | N/A |
| Ask: | 20.55 x 200 |
| 1y Target Est: | 27.44 |
| Day's Range: | 19.85 - 20.24 |
|---|---|
| 52wk Range: | 7.62 - 24.61 |
| Volume: | 18,606 |
| Avg Vol (3m): | 148,112 |
| Market Cap: | 572.04M |
| P/E (ttm): | N/A |
| EPS (ttm): | -2.10 |
| Div & Yield: | N/A (N/A) |
| Thu, Dec 17 | Anadys hepatitis C drug meets key study goalsAP |
| Wed, Dec 16 | Achillion shares rise on hepatitis C drug dataAP |
| Thu, Dec 3 | PHARMASSET INC FinancialsEDGAR Online Financials |
| Tue, Dec 1 | PHARMASSET INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online |
| Thu, Nov 26 | New Star Analyst Rankings for Pharmasset, Inc.StarMine |
| Wed, Nov 25 | Pharmasset Reports Fiscal Year End 2009 Financial ResultsPR Newswire |
| Wed, Nov 25 | PHARMASSET INC Files SEC form 10-K, Annual ReportEDGAR Online |
| Mon, Nov 23 | Pharmasset: hepatitis C drug trial will continueAP |
| Mon, Nov 23 | Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis CPR Newswire |
| Tue, Nov 17 | Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzzat TheStreet.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.